Company Description
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.
The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.
It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.
The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.
Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
| Country | United States |
| Founded | 2022 |
| IPO Date | Feb 21, 2025 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Brian Norton |
Contact Details
Address: 3000 Bayport Drive, Suite 950 Tampa, Florida 33607 United States | |
| Phone | (844) 203-6092 |
| Website | wellgisticshealth.com |
Stock Details
| Ticker Symbol | WGRX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.50 |
| CIK Code | 0002030763 |
| CUSIP Number | 949503106 |
| ISIN Number | US9495031067 |
| Employer ID | 93-3264234 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Brian Leonard Norton | Chief Executive Officer |
| Dr. Shafaat Pirani Pharm.D. | Chief Clinical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 30, 2025 | 8-K | Current Report |
| Jul 24, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jul 8, 2025 | 8-K | Current Report |
| May 15, 2025 | 8-K | Current Report |
| May 12, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | EFFECT | Notice of Effectiveness |
| May 7, 2025 | 424B3 | Prospectus |
| May 5, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Apr 24, 2025 | 8-K | Current Report |
| Apr 23, 2025 | UPLOAD | Filing |